{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:14:49Z","timestamp":1783577689593,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      To report aortic events in a large family carrying a variant in the\n                      <jats:italic>TGFBR2<\/jats:italic>\n                      gene.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Since 1990 up to 2024, we have conducted a longitudinal clinical study of a large single family comprising 63 members across four generations who carry the same\n                      <jats:italic>TGFBR2<\/jats:italic>\n                      pathogenic variant. We assessed the incidence of aortic events and prophylactic surgery, as well as life expectancy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a follow-up, 21 patients died (33% of the population), of whom ten were related to a dissection (48%). Eight patients underwent prophylactic aortic root surgery (13%). Over the generations, there is an increase in life expectancy and a decrease in the likelihood of aortic dissection (p\u2009&lt;\u20090.001), but no significant change in the combined endpoint of surgery, aortic dissection or death (p\u2009=\u20090.168). The type of prophylactic surgery has also evolved over the years from mechanical Bentall surgery to valve-sparing surgery. The variability in the age at onset of aortic events reflects the broad phenotypic spectrum of aortic disease associated with this variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Across four generations, improved diagnosis, prophylactic surgery, and surgical techniques were associated with reduced dissection rates and increased survival, despite marked intra-familial variability in aortic disease severity among carriers of the same\n                      <jats:italic>TGFBR2<\/jats:italic>\n                      pathogenic variant.\u201d\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04124-1","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:21:43Z","timestamp":1764242503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A large French family with TGFBR2 pathogenic variant: illustration of variability"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-804X","authenticated-orcid":false,"given":"Ludivine","family":"Eliahou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Milleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skerdi","family":"Haviari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Arnoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadima","family":"Toure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrine","family":"Jadoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arienne","family":"Mirmiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Jondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"4124_CR1","doi-asserted-by":"publisher","unstructured":"Jondeau G, Michel JB, Et C. Boileau. The translational science of marfan syndrome. Heart. 2011, 1 ao\u00fbt;97(n 15):120614.https:\/\/doi.org\/10.1136\/hrt.2010.212100.","DOI":"10.1136\/hrt.2010.212100"},{"key":"4124_CR2","doi-asserted-by":"publisher","unstructured":"Mizuguchi T, et al. Heterozygous TGFBR2 mutations in marfan syndrome. Nat Genet. ao\u00fbt 2004;36(n 8):85560, https:\/\/doi.org\/10.1038\/ng1392.","DOI":"10.1038\/ng1392"},{"key":"4124_CR3","doi-asserted-by":"publisher","unstructured":"Loeys BL, et al. Aneurysm syndromes caused by mutations in the TGF-\u03b2 receptor. NEJM Evid. 24 ao\u00fbt 2006;355(n 8):78898, https:\/\/doi.org\/10.1056\/NEJMoa055695.","DOI":"10.1056\/NEJMoa055695"},{"key":"4124_CR4","doi-asserted-by":"publisher","unstructured":"Attias D, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in marfan syndrome and related disorders. Circulation. 22 d\u00e9cembre 2009;120(n 25):254149, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.887042.","DOI":"10.1161\/CIRCULATIONAHA.109.887042"},{"key":"4124_CR5","doi-asserted-by":"publisher","unstructured":"Jondeau G, et al. Montalcino aortic consortium. International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (montalcino aortic consortium). Circ Cardiovasc Genet. 2016, Dec;9(6):548\u201358. https:\/\/doi.org\/10.1161\/CIRCGENETICS.116.001485. Epub 2016 Nov 21. PMID: 27879313; PMCID: PMC5177493.","DOI":"10.1161\/CIRCGENETICS.116.001485"},{"key":"4124_CR6","doi-asserted-by":"publisher","unstructured":"Pyeritz R, et al. Loeys\u2013dietz syndrome is a specific phenotype and not a concomitant of any mutation in a gene involved in TGF-\u03b2 signaling. Genet in Med. ao\u00fbt 2014;16(n 8):64142. https:\/\/doi.org\/10.1038\/gim.2014.63.","DOI":"10.1038\/gim.2014.63"},{"key":"4124_CR7","unstructured":"Arnaud, et al. Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD)."},{"issue":"9","key":"4124_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jacc.2022.05.054","volume":"80","author":"ES Regalado","year":"2022","unstructured":"Regalado ES, et al. Comparative risks of initial aortic events associated with genetic thoracic aortic disease. J Am Coll Cardiol. 2022, Aug, 30;80(9):857\u201369. PMID: 36007983.https:\/\/doi.org\/10.1016\/j.jacc.2022.05.054.","journal-title":"J Am Coll Cardiol"},{"key":"4124_CR9","doi-asserted-by":"publisher","unstructured":"Campens L, et al. Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. Am J Cardiol. 15 septembre 2014;114(n 6):91420, https:\/\/doi.org\/10.1016\/j.amjcard.2014.06.024.","DOI":"10.1016\/j.amjcard.2014.06.024"},{"key":"4124_CR10","unstructured":"Boileau C, et al. Autosomal dominant marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet. 1993 juillet;53(1):4654."},{"issue":"3","key":"4124_CR11","doi-asserted-by":"publisher","first-page":"26468","DOI":"10.1038\/ng1194-264","volume":"8","author":"G Collod","year":"1994","unstructured":"Collod G, et al. A second locus for marfan syndrome maps to chromosome 3p24.2\u2013P25. Nat Genet. 1994, novembre;8(3):26468. https:\/\/doi.org\/10.1038\/ng1194-264.","journal-title":"Nat Genet"},{"issue":"3","key":"4124_CR12","doi-asserted-by":"publisher","first-page":"27581","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys BL, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005, mar;37(3):27581. https:\/\/doi.org\/10.1038\/ng1511.","journal-title":"Nat Genet"},{"issue":"24","key":"4124_CR13","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.jacc.2025.04.023","volume":"85","author":"E Calderon-Martinez","year":"2025","unstructured":"Calderon-Martinez E, et al. Differences in arterial events in vascular ehlers-danlos, Loeys-Dietz, and marfan syndrome. J Am Coll Cardiol. 2025, Jun, 24;85(24):2355\u201367. PMID: 40533124.https:\/\/doi.org\/10.1016\/j.jacc.2025.04.023.","journal-title":"J Am Coll Cardiol"},{"issue":"n 36","key":"4124_CR14","doi-asserted-by":"publisher","first-page":"35383700","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, et al. 2024 esc guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024, septembre, 29;45(n 36):35383700. https:\/\/doi.org\/10.1093\/eurheartj\/ehae179.","journal-title":"Eur Heart J"},{"key":"4124_CR15","doi-asserted-by":"publisher","unstructured":"Writing Committee Members et al. 2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American heart Association\/American college of cardiology joint committee on clinical practice guidelines. J Am Coll Cardiol. 13 d\u00e9cembre 2022;80(n 24): e223393, https:\/\/doi.org\/10.1016\/j.jacc.2022.08.004.","DOI":"10.1016\/j.jacc.2022.08.004"},{"key":"4124_CR16","doi-asserted-by":"publisher","unstructured":"Bernhardt AMJ, et al. Comparison of aortic root replacement in patients with marfan syndrome. Eur J Criminol Cardio-Thorac Surg: Off J Eur Assoc Cardio-Thorac Surg. 2011, novembre;40(5):105257. https:\/\/doi.org\/10.1016\/j.ejcts.2011.02.018.","DOI":"10.1016\/j.ejcts.2011.02.018"},{"key":"4124_CR17","doi-asserted-by":"publisher","unstructured":"Price J, et al. Long-term outcomes of aortic root operations for marfan syndrome: a comparison of bentall versus aortic valve-sparing procedures. J Thorac Cardiovasc Surg. 2016 f\u00e9vrier;151(n 2): 33036, https:\/\/doi.org\/10.1016\/j.jtcvs.2015.10.068.","DOI":"10.1016\/j.jtcvs.2015.10.068"},{"issue":"n 8","key":"4124_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/heartjnl-2020-317036","volume":"107","author":"PD Thakker","year":"2021","unstructured":"Thakker PD, Braverman AC. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease. Heart (br Card Soc). 2021, avril;107(n 8):619\u201326. https:\/\/doi.org\/10.1136\/heartjnl-2020-317036.","journal-title":"Heart (br Card Soc)"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04124-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04124-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:21:44Z","timestamp":1764242504000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04124-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4124"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04124-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects in this study gave their written informed consent for participation in this clinical and genetic study in agreement with the requirements of French regulations. The personal protection committee of sud-M\u00e9diterrann\u00e9e I approved this study under the committee\u2019s reference number 21.04393.000082.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"611"}}